ESMS provides a 24-hour medical monitoring and emergency unblinding service for clinical trials, 7 days a week. With a global reach supporting over 300 studies covering more than 110 thousand subjects in 80 countries and with over 45 languages, we recognise patient safety is paramount.
Our unparalleled experience in providing 24/7 emergency response services allows us to provide strategic solutions to small, medium and global pharma companies.
Many in-house solutions can be fragmented and may be susceptible to failure which can result in major findings or serious breaches during a regulatory inspection. We receive many enquiries following such a regulatory inspection, suggesting that even the most comprehensive provision by a CRO or internal mechanism still may not be robust enough to stand up to scrutiny from the regulators.
Here at ESMS we have worked tirelessly to establish a mechanism that is continuously available and works to exceed regulatory requirements. We specialise in delivering a professional, robust and reliable continuous service.